# CVS HEALTH CORPORATION (CVS) FY2023 Annual Balance Sheet

- Company: CVS HEALTH CORPORATION (CVS)
- Period: As of 2023-12-31
- Filing: FY2023 10-K, filed 2024-02-07, accession number 0000064803-24-000007
- Page: https://plicit.ai/financials/cvs/fy2023-annual-balance-sheet
- Chart image: https://plicit.ai/charts/cvs-fy2023-annual-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2023-12-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 249,728,000,000 US dollars
- **Current assets**: 67,858,000,000 US dollars
- **Non-current assets**: 181,870,000,000 US dollars
- **Liabilities**: 173,092,000,000 US dollars
- **Current liabilities**: 79,189,000,000 US dollars
- **Non-current liabilities**: 93,903,000,000 US dollars
- **Equity**: 76,636,000,000 US dollars
- **Noncontrolling interest**: 175,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Accounts receivable, net**: 35,227,000,000 US dollars
- **Inventories**: 18,025,000,000 US dollars
- **Cash and cash equivalents**: 8,196,000,000 US dollars
- **Investments**: 3,259,000,000 US dollars
- **Other current assets**: 3,151,000,000 US dollars
- **Assets held for sale**: 0 US dollars
- **Goodwill**: 91,272,000,000 US dollars
- **Intangible assets, net**: 29,234,000,000 US dollars
- **Long-term investments**: 23,019,000,000 US dollars
- **Operating lease right-of-use assets**: 17,252,000,000 US dollars
- **Property and equipment, net**: 13,183,000,000 US dollars
- **Other assets**: 4,660,000,000 US dollars
- **Separate accounts assets**: 3,250,000,000 US dollars
- **Pharmacy claims and discounts payable**: 22,874,000,000 US dollars
- **Accrued expenses**: 22,189,000,000 US dollars
- **Accounts payable**: 14,897,000,000 US dollars
- **Health care costs payable**: 12,049,000,000 US dollars
- **Current portion of long-term debt**: 2,772,000,000 US dollars
- **Current portion of operating lease liabilities**: 1,741,000,000 US dollars
- **Policyholders’ funds**: 1,326,000,000 US dollars
- **Other insurance liabilities**: 1,141,000,000 US dollars
- **Short-term debt**: 200,000,000 US dollars
- **Liabilities held for sale**: 0 US dollars
- **Long-term debt**: 58,638,000,000 US dollars
- **Long-term operating lease liabilities**: 16,034,000,000 US dollars
- **Other long-term liabilities**: 6,211,000,000 US dollars
- **Other long-term insurance liabilities**: 5,459,000,000 US dollars
- **Deferred income taxes**: 4,311,000,000 US dollars
- **Separate accounts liabilities**: 3,250,000,000 US dollars
- **Retained earnings**: 61,604,000,000 US dollars
- **Common stock, par value $0.01: 3,200 shares authorized; 1,768 shares issued and 1,288 shares outstanding at December 31, 2023 and 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and capital surplus**: 48,992,000,000 US dollars
- **Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding**: 0 US dollars
- **Noncontrolling interests**: 175,000,000 US dollars
- **Treasury stock, at cost: 480 and 458 shares at December 31, 2023 and 2022**: negative 33,838,000,000 US dollars
- **Accumulated other comprehensive loss**: negative 297,000,000 US dollars
- **Gross equity (calculated)**: 110,771,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.